Sandrine Ferrand

DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance

Martin Schröder, Martin Renatus, Xiaoyou Liang et al. · Nature Communications · 2024 · 71 citations · Full text

Characterization of Rearrangements Involving the <i>ALK</i> Gene Reveals a Novel Truncated Form Associated with Tumor Aggressiveness in Neuroblastoma

Alex Cazes, Caroline Louis‐Brennetot, Pierre Mazot et al. · Cancer Research · 2012 · 65 citations · Full text

Cancer Biology, Tumor Biology, Neuro-oncology +19

Breakpoint Features of Genomic Rearrangements in Neuroblastoma with Unbalanced Translocations and Chromothripsis

Valentina Boeva, Stéphanie Jouannet, Romain Daveau et al. · PLoS ONE · 2013 · 42 citations · Full text

Cytogenetics, Genetics, Genomic Rearrangements +18

Statistical Evaluation of a Self-Deconvoluting Matrix Strategy for High-Throughput Screening of the CXCR3 Receptor

Sandrine Ferrand, Andres Schmid, Caroline Engeloch et al. · Assay and Drug Development Technologies · 2005 · 26 citations

Clinical Characteristics and Outcome of Patients with Neuroblastoma Presenting Genomic Amplification of Loci Other than MYCN

Anne Guimier, Sandrine Ferrand, Gaëlle Pierron et al. · PLoS ONE · 2014 · 23 citations · Full text